Xspray granted additional product patents in the United States for HyNap-Sora and HyNap-Nilo
STOCKHOLM – June 11, 2019. Xspray Pharma (Nasdaq First North: XSPRAY) announces that the United States Patent and Trademark Office (USPTO) has granted Xspray two new patents in the United States for its product candidates HyNap-Sora and HyNap-Nilo. The new patents are Xspray’s sixth and seventh product patents, respectively, in the United States, which is Xspray’s main market. The new patents will expire January 11, 2033.“The new patents for HyNap-Sora and HyNap-Nilo make it significantly more difficult for our competitors to copy upcoming products from our unique platform technology. The